STOCK TITAN

Addex Therapeutics (ADXN) Revenue by Year

ADXN NASDAQ

Addex Therapeutics Ltd generated $218K in revenue in fiscal year 2025. This represents a decrease of 51.8% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Addex Therapeutics Ltd has filed alongside them.

FY2025 annual
Revenue $218K
YoY -51.8%
5Y CAGR -45.2%
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ADXN Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-F
Revenue$218K-51.8%$452K-76.5%$1.9M+23.1%$1.6M-54.6%$3.4M-21.4%$4.4M+49.8%$2.9M-57.0%$6.8M+1228.0%$513K

ADXN Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ2'256-KQ1'256-KQ4'246-KQ2'246-KQ1'246-KQ4'2320-FQ2'236-KQ1'236-KQ4'2220-FQ2'226-KQ1'226-K
RevenueN/A$46K-64.3%N/AN/A$128K-81.9%N/AN/A$706K+261.8%N/AN/A$195K-83.1%N/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Addex Therapeutics Ltd financials

Frequently Asked Questions

Addex Therapeutics Ltd generated $218K in revenue in fiscal year 2025.

Addex Therapeutics Ltd (ADXN) revenue fell by 51.8% year over year, from $452K to $218K in fiscal year 2025.

Across the 9 fiscal years this page covers, Addex Therapeutics Ltd (ADXN) revenue went from $513K in fiscal year 2017 to $218K in fiscal year 2025.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Addex Therapeutics Ltd (ADXN) reported on that line in every period on record.